Gancotamab Uses, Dosage, Side Effects and more
Gancotamab is under investigation in clinical trial NCT02213744 (MM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast Cancer Patients).
| Attribute | Details |
|---|---|
| Trade Name | Gancotamab |
| Generic | Gancotamab |
| Gancotamab Other Names | Gancotamab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
